- Sector
- Healthcare
- Industry
- Medical Care Facilities
- IPO Date
- Sep 22, 2017
Highlights
- Market Cap
- $33.38M
- Enterprise Value
- $58.06M
- EPS (TTM)
- -$0.49
- Total Revenue (TTM)
- -$16.86M
- Gross Profit (TTM)
- -$2.95M
- EBITDA (TTM)
- -$41.99M
- Year Range
- $0.08 - $0.78
- ROA (TTM)
- -104.67%
- ROE (TTM)
- -248.22%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SRXH Performance Chart
SRx Health Solutions Inc (SRXH) is down 51.1% since the beginning of the year. At $0 per share, SRXH is trading 85.7% below its 52-week high of $1. Investors who bought $1,000 worth of SRXH shares 5 years ago would now be looking at an investment worth $0.
Loading charts...
Returns By Period
SRx Health Solutions Inc (SRXH) has returned -51.10% so far this year and -80.16% over the past 12 months.
SRx Health Solutions Inc
- 1D
- -10.36%
- 1M
- -12.13%
- YTD
- -51.10%
- 6M
- -62.55%
- 1Y
- -80.16%
- 3Y*
- -76.46%
- 5Y*
- -79.42%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
SRXH Monthly Returns History
Based on dividend-adjusted daily data since Sep 22, 2017, SRXH's average daily return is +2.49%, while the average monthly return is +31.07%. At this rate, an investment would double in approximately 0.2 years.
Historically, 40% of months were positive and 60% were negative. The best month was Mar 2019 with a return of +3,720.8%, while the worst month was May 2025 at -72.0%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.
On a daily basis, SRXH closed higher 41% of trading days. The best single day was Mar 18, 2019 with a return of +5,194.1%, while the worst single day was Mar 21, 2019 at -68.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -40.36% | -8.01% | 3.04% | -11.71% | -2.99% | 1.00% | -51.10% | ||||||
| 2025 | -18.25% | -14.64% | 4.88% | 12.79% | -71.97% | 10.32% | -33.27% | 4.37% | -24.13% | -5.36% | 14.00% | -33.27% | -90.29% |
| 2024 | -24.08% | -11.90% | -18.92% | -11.33% | -24.25% | -3.23% | -17.95% | 0.62% | -35.09% | -12.92% | 8.79% | 18.69% | -78.76% |
| 2023 | 37.27% | -4.80% | -47.47% | 11.08% | -29.44% | -27.59% | 10.57% | -17.74% | -35.08% | 72.50% | 58.95% | -18.65% | -48.68% |
| 2022 | -29.10% | 20.52% | -7.61% | -15.29% | 20.83% | -15.71% | 8.18% | -23.53% | -56.27% | 29.43% | -33.91% | -20.82% | -83.31% |
| 2021 | 18.11% | -6.67% | 2.86% | -3.47% | -7.91% | -44.01% | -18.60% | 5.71% | 0.27% | 4.58% | -3.09% | -14.10% | -57.61% |
Benchmark Metrics
SRx Health Solutions Inc has an annualized alpha of 40368.29%, beta of 1.30, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since September 22, 2017.
- This stock participated in 168.36% of S&P 500 Index downside but only -88.23% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 40,368.29%
- Beta
- 1.30
- R²
- 0.00
- Upside Capture
- -88.23%
- Downside Capture
- 168.36%
Return for Risk
Risk / Return Rank
SRXH ranks 17 for risk / return — in the bottom 17% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for SRx Health Solutions Inc (SRXH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SRXH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.51 | ||
| Sortino ratioReturn per unit of downside risk | -3.07 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.37 | -0.41 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 2.78 | -3.74 |
| Martin ratioReturn relative to average drawdown | -1.24 | 12.44 | -13.68 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the SRx Health Solutions Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the SRx Health Solutions Inc was 99.99%, occurring on Feb 9, 2026. The portfolio has not yet recovered.
The current SRx Health Solutions Inc drawdown is 99.99%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -99.99%Feb 2026 | 6y 9mo | — | 7y 1moMay 2019 - now |
2019 bear market2019 | -94.74%Jan 2019 | 8mo 4d | 1mo 18d | 9mo 22dMay 2018 - Mar 2019 |
2019 bear market2019 | -68.89%Mar 2019 | 0s | 1mo 24d | 1mo 24dMar 2019 - May 2019 |
2017 bear market2017 | -50.82%Nov 2017 | 1mo 8d | 3mo 21d | 4mo 29dSep 2017 - Feb 2018 |
2018 correction2018 | -14.75%Mar 2018 | 11d | 1mo 14d | 1mo 25dFeb 2018 - Apr 2018 |
Drawdown Indicators
| SRXH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -56.78% | -43.21% |
Max Drawdown (1Y)Largest decline over 1 year | -84.10% | -9.10% | -75.00% |
Max Drawdown (3Y)Largest decline over 3 years | -99.25% | -18.90% | -80.35% |
Max Drawdown (5Y)Largest decline over 5 years | -99.96% | -25.43% | -74.53% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.99% | -1.80% | -98.19% |
Average DrawdownAverage peak-to-trough decline | -84.87% | -10.71% | -74.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 64.67% | 2.03% | +62.64% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of SRx Health Solutions Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how SRx Health Solutions Inc is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SRXH in comparison with other companies in the Medical Care Facilities industry. Currently, SRXH has a P/B value of 1.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SRXH
Add SRx Health Solutions Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SRXH